Opioid antagonist (μ-receptor) — reversal agent for opioid overdose
Naloxone
นาล็อกโซน
ชื่อทางการค้า · Narcan
กลไกการออกฤทธิ์ · Mechanism
TEMPLATE — mechanism pending Thai translation + faculty review (cross-check DailyMed + WHO ATC + PubChem + WHO Essential Medicines List)
ข้อบ่งใช้ · Indications
ข้อห้ามใช้ · Contraindications
ขนาดยา · Dosage
ผลข้างเคียง · Side effects
References
- 1regulatory-database · Naloxone — NLM DailyMed (FDA Structured Product Labeling), 2025upstream ↗c/d5624790…a8f7Cross-checked source: FDA-approved labeling. Search by name returns relevant product labelings.
- 2guideline · ATC V03AB15 — Naloxone, 2025upstream ↗c/ac3dc44a…97c4Cross-checked source: WHO Collaborating Centre ATC/DDD index. Authoritative drug classification.
- 3monograph · Naloxone — PubChem search, 2025upstream ↗c/c3d4d72c…f57fCross-checked source: chemical structure, identifiers, pharmacology summary. Faculty review fills exact CID.
- 4guideline · WHO Model List of Essential Medicines (22nd List, 2021), 2021upstream ↗c/71030c79…53ebCross-checked source: drug appears on WHO EML — WHO recognizes its place in basic healthcare.